BioSpace News Archive

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Gavi, the Vaccine Alliance has exercised its option to purchase an additional 176.5 million doses of the Moderna COVID-19 vaccine for the COVAX Facility.

Araris Biotech AG announced that data from its linker technology are being presented at the 12th annual World ADC San Diego Conference - The Digital Edition.

Mosaic ImmunoEngineering Inc. today announced that Nicole F. Steinmetz, Ph.D., acting chief scientific officer and co-founder of Mosaic and the director of the UC San Diego Center for Nano-ImmunoEngineering, delivered a Spotlight Presentation at the World Molecular Imaging Congress (WMIC) on Friday, October 8, 2021.

Creative Medical Technology Holdings Inc. announced today proof of concept data demonstrating the ability of its next generation ImmCelz™ immunotherapy product to “reprogram” patient immune cells using the Company’s patent pending “ex vivo cell-free” reprogramming protocol.

GeneCentric Therapeutics today announced a new strategic collaboration with Labcorp, a leading global life sciences company, to develop and commercialize new RNA-based gene signatures as diagnostics for people with cancer.

Hunterian Medicine ® Licenses Inscripta’s MAD7™ Nuclease to Advance Gene Editing Research and Development

Istari Oncology, Inc. today announced its first patient was dosed in the company’s LUMINOS-103 bladder cancer sub-study (NCT04690699).

First Wave BioPharma, Inc., today announced additions to the Company’s Scientific Advisory Board (SAB) to reflect the expanded clinical development opportunities into COVID-19-related gastrointestinal infections

Agenus Inc. (NASDAQ: AGEN), today announced it has triggered the first development milestone payment under its global licensing agreement with Bristol Myers Squibb for AGEN1777, an Fc-enhanced bispecific anti-TIGIT antibody.

Halberd Corporation (OTC PINK:HALB) and GTX Corp. (OTC PINK:GTXO) have agreed to work together on various neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, PTSD/CTE (Chronic Traumatic Encephalopathy)/ Traumatic Brain Injury), among others.